Immuron Completes Small Shareholder Buyback, Cancels 3.8M Shares
IMRN sits 54% above its 52-week low of $0.677 on light trading volume (0.3× avg).
Summary
Immuron Ltd completed its small shareholder buyback program, cancelling 3.8 million shares to streamline its capital structure and reduce administrative expenses.
Key Events · Financing and Capital Events · IMRN
-
Share Buyback Completed
Immuron completed its small holding share sale facility, initially announced on April 13, 2026.
-
3.8 Million Shares Cancelled
The company bought back and cancelled 3,805,528 shares, representing approximately 1.16% of its pre-buyback outstanding shares.
-
$121,777 Value
The aggregate value of the shares acquired and cancelled was $121,777, at a volume-weighted average price of $0.032 per share.
-
Reduced Shareholder Count
The number of shareholders decreased from 2,264 to 1,253, aiming to reduce administrative costs.
Analysis · IMRN · Life Sciences
Immuron Ltd has finalized its small holding share sale facility, buying back and cancelling 3.8 million shares valued at $121,777. This action, which reduces the total outstanding shares by approximately 1.16% and significantly cuts the number of shareholders, is aimed at reducing administrative costs.
How filings like this one have moved
In the 30 days to Aug 26, 2026, 29.6% of the 2932 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IMRN was trading at $1.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.68 to $2.39. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.